(Q44538319)

English

Effect of maternal administration of selective cyclooxygenase (COX)-2 inhibitors on renal size, growth factors, proteinases, and COX-2 secretion in the fetal rabbit

scientific article published on 24 January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Effect of maternal administration of selective cyclooxygenase (COX)-2 inhibitors on renal size, growth factors, proteinases, and COX-2 secretion in the fetal rabbit (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

author name string

Jeffrey Y Hartleroad

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Kay D Beharry

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Nicole Hausman

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Yuri Stavitsky

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Tamerou Asrat

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Houchang D Modanlou

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

24 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

246-253

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Cyclooxygenase-1 and -2 isoenzymes

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2.

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Loss, restoration, and maintenance of plasma membrane integrity

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Response of fetal prostanoids, nitric oxide, and ductus arteriosus to the short- and long-term antenatal administration of celecoxib, a selective cyclo-oxygenase-2 inhibitor, in the pregnant rabbit

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Cyclooxygenase-2: a therapeutic target in angiogenesis.

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term

1 reference

https://api.crossref.org/works/10.1159%2F000083588

21 January 2018

Identifiers

10.1159/000083588

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44538319&oldid=2134969189"